Treating Spinal Cord Injury With Early Normobaric Hyperoxia
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT07465302
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Traumatic Spinal Cord Injuries
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Normobaric Hyperoxia — OTHERIntermittent normobaric hyperoxia (NBH) by increasing FiO2 to 100% for a duration of 4.5h (270 min), twice daily over five consecutive days. Instead of fixed 12-hour intervals between sessions, the two daily treatments will follow a pre-specified interval: a minimum of 1.5h (90min) between sessions for treatment B, and 10h (600min) for treatment A.
Study Details
SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.
Key Dates
- Start date
- Apr 15, 2026
- Status verified
- Feb 2026
- Primary completion
- Mar 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: InterventionNormobaric hyperoxia
Primary Outcome Measure
Feasibility of early normobaric hyperoxic therapy [ Time Frame: 24 hours from injury ]
Central Contacts
- Andrew Kline352-273-9000
- Ralisa Pop(352) 294-5693
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Florida | Gainesville | Florida | 32610 |
Find similar trials in Gainesville, FL
By research site